Narcolepsy - when diagnosis doesn't meet all the criteria – case report
Caroline dos Reis Lopes, Cláudia Loureiro Gomes, Núria Madureira
Abstract
Open-access reader
Caroline dos Reis Lopes, Cláudia Loureiro Gomes, Núria Madureira
Abstract
Open-access reader
Narcolepsy is a rare chronic sleep disorder characterized by a pentad of clinical symptoms: excessive daytime sleepiness, cataplexy, hypnagogic or hypnopompic hallucinations, sleep paralysis and disturbance of nocturnal sleep. The presence of cataplexy defines Narcolepsy Type 1 (NT1), an auto-immune disease with destruction of hypocretin -1 (hcrt1) neurons and low hcrt1 levels in cerebrospinal fluid (CSF). We present a case of an adolescent with excessive daytime sleepiness and cataplexy with normal levels of hcrt1 in CSF. The literature describes about ten percent of NT1 cases with normal CSF hcrt1 levels.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Narcolepsy is a rare chronic sleep disorder characterized by a pentad of clinical symptoms: excessive daytime sleepiness, cataplexy, hypnagogic or hypnopompic hallucinations, sleep paralysis and disturbance of nocturnal sleep. The presence of cataplexy defines Narcolepsy Type 1 (NT1), an auto-immune disease with destruction of hypocretin -1 (hcrt1) neurons and low hcrt1 levels in cerebrospinal fluid (CSF). We present a case of an adolescent with excessive daytime sleepiness and cataplexy with normal levels of hcrt1 in CSF. The literature describes about ten percent of NT1 cases with normal CSF hcrt1 levels.
Key concepts: Narcolepsy, Sleep paralysis, Cataplexy, Excessive daytime sleepiness, Sleep disorder, Medicine, Psychology, Cerebrospinal fluid